Equities Research Analysts’ updated eps estimates for Tuesday, August 8th:

Apple (NASDAQ:AAPL) had its neutral rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $150.00 price target on the stock, up from their previous price target of $120.00.

AECOM (NYSE:ACM) had its hold rating reaffirmed by analysts at Canaccord Genuity. They currently have a $36.00 target price on the stock.

Aegion Corp (NASDAQ:AEGN) was downgraded by analysts at Sidoti from a buy rating to a neutral rating.

Asanko Gold (NYSEMKT:AKG) (TSE:AKG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Asanko Gold Inc. is a gold producer with its flagship asset, the Asanko Gold Mine, located in Ghana, West Africa. Asanko Gold Inc., formerly known as Keegan Resources Inc., is based in Vancouver, Canada. “

Alder BioPharmaceuticals (NASDAQ:ALDR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington. “

Allstate Corporation (The) (NYSE:ALL) was downgraded by analysts at Deutsche Bank AG from a buy rating to a hold rating. Deutsche Bank AG currently has $96.00 target price on the stock, up from their previous target price of $90.00.

AMC Entertainment Holdings (NYSE:AMC) had its buy rating reaffirmed by analysts at Loop Capital. Loop Capital currently has a $33.00 target price on the stock, down from their previous target price of $39.00.

AMC Entertainment Holdings (NYSE:AMC) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $23.00 price target on the stock.

Blue Apron Holdings (NASDAQ:APRN) had its buy rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $10.00 price target on the stock.

Arena Pharmaceuticals (NASDAQ:ARNA) had its hold rating reiterated by analysts at Needham & Company LLC. The analysts wrote, “Arena mgmt hosted a conference call yesterday to provide a 2Q17 quarterly corporate update. Company announced positive results from a 61-pt Phase 2 trial of ralinepag in Pulmonary Arterial Hypertension (PAH) in Jul 2017. We await insight into FDA and EMA requirements for registration. Mgmt is not providing specific guidance, but we assume mtgs can be scheduled by YE17. Other upcoming milestones include top-line results from Phase 2 trials of etrasimod in Ulcerative Colitis (YE17) and APD-371 in pain associated with Crohn’s Disease (YE17).””

American Vanguard Corporation (NYSE:AVD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

BMC Stock Holdings (NASDAQ:BMCH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “BMC Stock Holdings Inc provides diversified building products and services to professional builders and contractors primarily in the residential housing market. The Company’s portfolio of products and services spans building materials includes millwork and structural component manufacturing capabilities, consultative showrooms and design centers, value-added installation management and eBusiness platform. BMC Stock Holdings, Inc., formerly known as Stock Building Supply Holdings, is headquartered in Raleigh, North Carolina. “

Peabody Energy Corporation (NYSE:BTU) had its hold rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $32.00 price target on the stock, up from their previous price target of $30.00.

Burlington Stores (NYSE:BURL) had its buy rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $115.00 price target on the stock.

Continental Building Products (NYSE:CBPX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Continental Building Products, Inc. is a manufacturer of gypsum wallboard, joint compound and complementary finishing products. It serves the residential, commercial and repair and remodel construction markets primarily in the eastern United States and eastern Canada. The company sells its products under the LiftLite, Mold Defense and Weather Defense names. Continental Building Products, Inc. is headquartered in Silver Grove, Quebec. “

CBS Corporation (NYSE:CBS) had its buy rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $80.00 price target on the stock.

ChemoCentryx (NASDAQ:CCXI) had its hold rating reissued by analysts at Cowen and Company. The analysts wrote, “ChemoCentryx reported Q2 financials, including a net loss of $9.2MM and a June 30.””

Cognex Corporation (NASDAQ:CGNX) had its outperform rating reissued by analysts at Cowen and Company. They currently have a $135.00 target price on the stock, up from their previous target price of $100.00.

Clearwater Paper Corp (NYSE:CLW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Clearwater Paper,a standalone company,produces pulp and paperboard at six facilities across the country namely Lewiston, Idaho; Las Vegas, Nev.; Elwood, Ill.; and near McGehee, Ark. The company manufactures quality paperboard, consumer tissue, and wood products.It has direct access to the public capital markets .The company is a premier supplier of private label tissue to major retail grocery chains, and also produces bleached paperboard used by quality-conscious printers and packaging converters. “

Corvus Pharmaceuticals (NASDAQ:CRVS) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $26.00 price target on the stock.

Cisco Systems (NASDAQ:CSCO) had its buy rating reaffirmed by analysts at Deutsche Bank AG. They currently have a $40.00 price target on the stock.

CytomX Therapeutics (NASDAQ:CTMX) had its hold rating reiterated by analysts at Cann. The analysts wrote, “Loss per share was $0.69, compared to our estimate of $0.56. This was the result of higher than expected R&D expense of $28.1 million compared to our estimate of $15.2 million, which resulted from a $10 million payment to UCSB for a sublicense payment. This was partially offset by higher than estimated revenue of $8.8 million compared to our estimated $1.0 million.””

CytomX Therapeutics (NASDAQ:CTMX) had its buy rating reissued by analysts at Cowen and Company.

CVR Refining, (NYSE:CVRR) had its neutral rating reissued by analysts at UBS AG. They currently have a $8.50 price target on the stock, down from their previous price target of $10.00.

Ecolab (NYSE:ECL) had its buy rating reiterated by analysts at UBS AG. They currently have a $147.00 price target on the stock, up from their previous price target of $144.00.

EP Energy Corporation (NYSE:EPE) had its hold rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $3.00 price target on the stock.

FireEye (NASDAQ:FEYE) had its market perform rating reiterated by analysts at BMO Capital Markets. The firm currently has a $17.00 price target on the stock, up from their previous price target of $15.00.

FireEye (NASDAQ:FEYE) had its buy rating reissued by analysts at BTIG Research. They currently have a $18.00 target price on the stock, up from their previous target price of $17.00.

FireEye (NASDAQ:FEYE) had its hold rating reiterated by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $15.00 price target on the stock.

Frontier Communications Corporation (NASDAQ:FTR) had its neutral rating reiterated by analysts at UBS AG. The firm currently has a $15.00 price target on the stock, down from their previous price target of $26.25.

General Mills (NYSE:GIS) had its hold rating reiterated by analysts at BMO Capital Markets.

Hanesbrands (NYSE:HBI) had its buy rating reiterated by analysts at UBS AG. They currently have a $27.00 price target on the stock, up from their previous price target of $25.00.

Karyopharm Therapeutics (NASDAQ:KPTI) had its buy rating reaffirmed by analysts at Canaccord Genuity. The firm currently has a $18.00 price target on the stock.

Kornit Digital (NASDAQ:KRNT) had its buy rating reiterated by analysts at Canaccord Genuity. The firm currently has a $24.00 price target on the stock.

Grand Canyon Education (NASDAQ:LOPE) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $89.00 price target on the stock, up from their previous price target of $85.00.

Mosaic Company (The) (NYSE:MOS) had its hold rating reiterated by analysts at Stifel Nicolaus. They currently have a $24.00 price target on the stock, down from their previous price target of $27.00.

MyoKardia (NASDAQ:MYOK) had its buy rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $45.00 price target on the stock.

Nevro Corp. (NYSE:NVRO) had its buy rating reissued by analysts at Northland Securities. Northland Securities currently has a $96.00 target price on the stock.

Omeros Corporation (NASDAQ:OMER) had its buy rating reissued by analysts at Maxim Group. They currently have a $24.00 price target on the stock, up from their previous price target of $23.00.

Children’s Place, Inc. (The) (NASDAQ:PLCE) had its hold rating reaffirmed by analysts at BMO Capital Markets. They currently have a $112.00 target price on the stock.

Pharmerica Corporation (NYSE:PMC) was downgraded by analysts at KeyCorp to an overweight rating.

Primerica (NYSE:PRI) had its hold rating reaffirmed by analysts at Wells Fargo & Company. The analysts wrote, “We are concerned that some of the recent growth is of low quality, and prone to lapsation in early years.””

Proteon Therapeutics (NASDAQ:PRTO) had its hold rating reissued by analysts at Cowen and Company.

Royal Caribbean Cruises (NYSE:RCL) had its buy rating reiterated by analysts at UBS AG. They currently have a $131.00 price target on the stock, up from their previous price target of $112.00.

Rice Energy (NYSE:RICE) had its buy rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $28.00 target price on the stock.

Ross Stores (NASDAQ:ROST) had its hold rating reaffirmed by analysts at BMO Capital Markets. They currently have a $65.00 target price on the stock.

RSP Permian (NYSE:RSPP) had its buy rating reiterated by analysts at BMO Capital Markets. They currently have a $38.00 target price on the stock.

Sprint Corporation (NYSE:S) had its market perform rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $6.50 price target on the stock.

Sucampo Pharmaceuticals (NASDAQ:SCMP) had its buy rating reaffirmed by analysts at Maxim Group. Maxim Group currently has a $23.00 target price on the stock, up from their previous target price of $21.00.

Spirit Aerosystems Holdings (NYSE:SPR) had its outperform rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $79.00 target price on the stock, up from their previous target price of $69.00.

Terex Corporation (NYSE:TEX) had its buy rating reaffirmed by analysts at UBS AG. They currently have a $44.00 target price on the stock, up from their previous target price of $40.00.

Teligent (NASDAQ:TLGT) had its buy rating reaffirmed by analysts at Canaccord Genuity. The analysts wrote, “We’re confident that the company’s revised expectations are achievable and delays at the agency will resolve in short order. We continue to view Teligent as a uniquely positioned generic company poised for meaningful growth over the next several years. We maintain our BUY rating and $11 price target on TLGT shares. Light revenue due to lidocaine ointment and Zantac; lidocaine solution a surprising star in the report. Teligent’s 2Q/17 revenue was $18.4 mm compared to our $19mm estimate and $20.3 mm consensus. In our post-launch thoughts, we believed investors were expecting a light quarter and potential downward revision to 2H/17 expectations. Adjusted loss per share was ($0.01) compared to our EPS estimate of +$0.01 and consensus of +$0.02. Teligent saw incremental competition and double-digit price erosion on lidocaine ointment and a return of a competitor on Zantac injection coupled with lower-than-expected Zantac utilization rates due to recent inventory shortages that changed physician use patterns.””

Two Harbors Investments Corp (NYSE:TWO) had its buy rating reiterated by analysts at Maxim Group. They currently have a $10.25 price target on the stock.

Voyager Therapeutics (NASDAQ:VYGR) had its buy rating reiterated by analysts at Cowen and Company. The analysts wrote, “VYGR had a 6/30 cash balance of $141MM, sufficient to fund operations into 2019.””

Wayfair (NYSE:W) had its buy rating reaffirmed by analysts at Canaccord Genuity. The analysts wrote, “We were encouraged by higher acquisition activity during the quarter, which should help offset the expected continuation of volume headwinds that much of the industry is experiencing.””

Xencor (NASDAQ:XNCR) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $36.00 target price on the stock.

Xerox Corporation (NYSE:XRX) had its buy rating reiterated by analysts at Loop Capital. Loop Capital currently has a $38.00 target price on the stock, up from their previous target price of $36.00.

Zynerba Pharmaceuticals (NASDAQ:ZYNE) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $28.00 price target on the stock.

Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.